Who are Rendu Biotechnology's investors?

Rendu Biotechnology's investors include Qiming VP.

When was Rendu Biotechnology founded?

Rendu Biotechnology was founded in 2007.

Where is Rendu Biotechnology headquartered?

Rendu Biotechnology is headquartered in Shanghai, China.

What industry is Rendu Biotechnology in?

Rendu Biotechnology operates in Biotech, Healthcare.

Rendu Biotechnology

IPO

Focused on RNA detection technology innovation

Shanghai, China · Founded 2007

Biotech

Healthcare

Headquarters: Shanghai
Founded: 2007
Business Model: B2B

Website: rdbio.com
Last Round: Venture RoundJun 2019
Rounds: 3

About

Shanghai Rendu Biotechnology Co., Ltd. (Sci Tech Innovation Edition, stock code: 688193) is a Chinese biotech company focused on RNA detection technology innovation. Founded in 2007 and headquartered in the Zhangjiang High-tech Park in Shanghai, the company has over 17 years of expertise in RNA diagnostics. Its products cover five major clinical areas: reproductive health, blood-borne infectious diseases, respiratory infections, enteroviruses, and tumor early screening. The company serves over 700 medical institutions and holds 97 domestic and foreign patents, including two world-first launched products.

Summary

Rendu Biotechnology is a Biotech company based in Shanghai, China, founded in 2007. Its most recent funding was a Venture Round round in Jun 2019. Investors include Qiming VP.